Index RUT
P/E -
EPS (ttm) -1.77
Insider Own 54.38%
Shs Outstand 41.13M
Perf Week 9.01%
Market Cap 708.22M
Forward P/E -
EPS next Y -3.17
Insider Trans 2.62%
Shs Float 22.64M
Perf Month 11.14%
Income -71.90M
PEG -
EPS next Q -0.69
Inst Own 37.37%
Short Float 3.86%
Perf Quarter 1.71%
Sales 0.00M
P/S -
EPS this Y -45.98%
Inst Trans -
Short Ratio 5.42
Perf Half Y 63.09%
Book/sh 5.86
P/B 2.43
EPS next Y -9.26%
ROA -39.28%
Short Interest 0.87M
Perf Year -14.76%
Cash/sh 4.77
P/C 2.99
EPS next 5Y -
ROE -41.38%
52W Range 5.85 - 17.70
Perf YTD 65.93%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -29.81%
52W High -19.38%
Beta 2.16
Dividend TTM -
Quick Ratio 23.76
Sales past 5Y 0.00%
Gross Margin -
52W Low 143.93%
ATR (14) 0.77
Dividend Ex-Date -
Current Ratio 23.76
EPS Y/Y TTM -
Oper. Margin 0.00%
RSI (14) 63.95
Volatility 7.16% 5.88%
Employees 28
Debt/Eq 0.00
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 33.67
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q -173.89%
Payout -
Rel Volume 1.18
Prev Close 14.65
Sales Surprise -
EPS Surprise -4.79%
Sales Q/Q -
Earnings May 09 BMO
Avg Volume 160.91K
Price 14.27
SMA20 15.34%
SMA50 9.98%
SMA200 30.29%
Trades
Volume 189,561
Change -2.59%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-02-24 Initiated
Goldman
Buy
$30
Mar-07-23 Initiated
Wells Fargo
Overweight
$27
Mar-07-23 Initiated
Stifel
Buy
$45
Mar-07-23 Initiated
Guggenheim
Buy
$32
Mar-07-23 Initiated
Evercore ISI
Outperform
Mar-07-23 Initiated
Credit Suisse
Outperform
$40
Mar-07-23 Initiated
BofA Securities
Buy
$39
Today 11:56AM
07:00AM
May-06-24 08:00AM
May-02-24 08:00AM
Apr-05-24 12:16AM
10:51AM
Loading…
Mar-22-24 10:51AM
Mar-21-24 11:53AM
09:11AM
07:00AM
Mar-13-24 04:05PM
Feb-08-24 08:00AM
Jan-29-24 04:05PM
Jan-17-24 12:00PM
Jan-04-24 04:05PM
Dec-21-23 04:05PM
09:22AM
Loading…
Nov-12-23 09:22AM
Nov-11-23 11:30AM
Nov-09-23 04:05PM
Nov-07-23 05:12PM
04:05PM
Nov-02-23 10:00AM
Oct-31-23 04:05PM
Oct-13-23 04:10PM
Sep-19-23 04:00PM
Sep-14-23 04:05PM
Sep-11-23 04:05PM
Sep-10-23 07:47AM
07:45AM
Sep-09-23 05:00AM
Sep-05-23 04:05PM
09:55AM
Loading…
09:55AM
Aug-29-23 04:05PM
Aug-22-23 05:45PM
Aug-07-23 04:05PM
Jul-31-23 04:05PM
Jul-17-23 04:01PM
Jun-09-23 08:04AM
May-31-23 08:00AM
May-15-23 04:01PM
May-10-23 08:39AM
May-02-23 08:00AM
May-01-23 08:00AM
Apr-27-23 04:47PM
Mar-15-23 04:01PM
Mar-04-23 04:30PM
Mar-01-23 04:05PM
Feb-20-23 08:00AM
Feb-17-23 12:08PM
(American City Business Journals)
Feb-14-23 04:01PM
Feb-10-23 05:16PM
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rodman David Malcom Chief Medical Officer Apr 12 '24 Option Exercise 1.08 6,349 6,857 66,997 Apr 15 04:24 PM Rodman David Malcom Chief Medical Officer Apr 11 '24 Option Exercise 0.54 5,017 2,709 60,648 Apr 15 04:24 PM Rodman David Malcom Chief Medical Officer Mar 12 '24 Option Exercise 1.08 6,348 6,856 55,631 Mar 13 05:35 PM Rodman David Malcom Chief Medical Officer Mar 11 '24 Option Exercise 0.54 5,017 2,709 49,283 Mar 13 05:35 PM Rodman David Malcom Chief Medical Officer Feb 12 '24 Option Exercise 0.84 11,366 9,566 44,266 Feb 13 04:08 PM Samsara BioCapital GP, LLC 10% Owner Feb 12 '24 Buy 13.50 555,555 7,499,992 5,074,916 Feb 14 09:06 PM Rodman David Malcom Chief Medical Officer Jan 12 '24 Option Exercise 1.08 6,348 6,856 32,900 Jan 12 04:01 PM Rodman David Malcom Chief Medical Officer Jan 11 '24 Option Exercise 0.54 5,017 2,709 26,552 Jan 12 04:01 PM Rodman David Malcom Chief Medical Officer Dec 11 '23 Option Exercise 0.54 5,018 2,710 20,069 Dec 12 05:08 PM Congleton Jon Chief Executive Officer Nov 22 '23 Buy 5.97 4,250 25,356 1,049,068 Nov 27 04:01 PM Rodman David Malcom Chief Medical Officer Nov 13 '23 Option Exercise 0.54 5,017 2,709 15,051 Nov 14 06:18 PM Rodman David Malcom Chief Medical Officer Nov 03 '23 Option Exercise 0.54 10,034 5,418 10,034 Nov 07 05:15 PM Congleton Jon Chief Executive Officer Sep 06 '23 Buy 12.08 2,250 27,180 1,044,818 Sep 08 08:49 AM Congleton Jon Chief Executive Officer Aug 17 '23 Buy 12.10 2,250 27,225 1,042,568 Aug 21 04:03 PM Rodman David Malcom Chief Medical Officer Aug 11 '23 Option Exercise 0.80 157,091 125,967 80,909 Aug 11 07:11 PM Congleton Jon Chief Executive Officer Aug 11 '23 Buy 12.89 2,000 25,780 1,040,318 Aug 11 07:11 PM Rodman David Malcom Chief Medical Officer Aug 11 '23 Sale 12.81 157,091 2,012,336 0 Aug 11 07:11 PM Rodman David Malcom Chief Medical Officer Aug 10 '23 Option Exercise 0.54 74,625 40,298 74,625 Aug 11 07:11 PM Rodman David Malcom Chief Medical Officer Aug 10 '23 Sale 13.16 74,625 982,065 0 Aug 11 07:11 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite